Evan Floden is the co-founder and CEO of Seqera, a pioneering company streamlining data pipeline orchestration for scientific research and biotech innovation.

With a background in computational biology, he helped create the widely adopted open-source workflow platform Nextflow, now powering global advances in genomics and life sciences. Seqera became world’s most indispensable software-first platform for bioinformatics and life science R&D, backed by Addition, Speedinvest, Talis, Amino Collective, BoxOne, and SNR, with offices in Barcelona, New York, Boston and London.

Seqera has raised more than $50 million USD in VC funding and supports 150 customers including 13 of the top 20 global pharma companies.